Richard L. Lieber
Works at
25 Jun 2025, reporter.nih.gov
Grants and prizes
I21, Pre-clinical study for the use of D3-Creatine as a biomarker in cachexia clinical trials, I21RX005146, 2024–2026, 25 Jun 2025, reporter.nih.gov
25 Jun 2025, reporter.nih.gov
I21, Pre-clinical study for the use of D3-Creatine as a biomarker in cachexia clinical trials, I21RX005146, 2024–2026, 25 Jun 2025, reporter.nih.gov